Valuation: C-Rad AB

Market Cap 1.22B 129M 112M 104M 95.27M 180M 12.29B 182M 480M 6.15B 484M 473M 20.47B P/E 2026 *
18.3x
P/E 2027 * 15.3x
Enterprise Value 1.05B 111M 95.94M 89.67M 81.96M 154M 10.57B 157M 413M 5.29B 416M 407M 17.61B EV / Sales 2026 *
2.27x
EV / Sales 2027 * 1.92x
Free-Float
50.36%
Yield 2026 *
1.24%
Yield 2027 * 1.8%
Manager TitleAgeSince
Chief Executive Officer 56 02/02/2026
Chief Executive Officer - 21/10/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 52 01/01/2017
Director/Board Member 60 07/05/2021
Chairman 61 05/05/2023
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 129M
+0.96%+4.47%+30.16%+9.58% 222B
+2.25%+6.01%+4.39%-18.65% 147B
+3.85%+4.79%-16.32%+29.12% 139B
+2.33%+4.19%-51.08%-0.79% 73.13B
+2.57%+3.61%+17.46%+17.57% 53.05B
-0.09%+0.31%-14.75%-17.10% 50.36B
+1.88%+6.38%+29.75%+16.51% 42B
+1.21%+9.88%+46.43%+42.33% 40.43B
+1.63%+4.60%+1.31%+0.89% 32.95B
Average +1.66%+217.53%+5.26%+8.83% 88.87B
Weighted average by Cap. +1.95%+308.18%+5.86%+7.34%

Financials

2026 *2027 *
Net sales 464M 48.89M 42.32M 39.56M 36.15M 68.13M 4.66B 69.2M 182M 2.33B 184M 180M 7.77B 527M 55.54M 48.08M 44.94M 41.08M 77.4M 5.3B 78.61M 207M 2.65B 209M 204M 8.83B
Net income 66.84M 7.04M 6.1M 5.7M 5.21M 9.82M 672M 9.97M 26.23M 336M 26.45M 25.87M 1.12B 79.63M 8.39M 7.27M 6.79M 6.21M 11.7M 800M 11.88M 31.25M 400M 31.51M 30.83M 1.33B
Net Debt -171M -18M -15.58M -14.57M -13.31M -25.09M -1.72B -25.48M -67.02M -859M -67.59M -66.11M -2.86B -209M -21.99M -19.04M -17.79M -16.26M -30.64M -2.1B -31.12M -81.87M -1.05B -82.56M -80.76M -3.49B
Logo C-Rad AB
C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.
Employees
98
Trader
Investor
Global
Quality
ESG MSCI
-